Pulmonary arterial hypertension

• Phase Ib Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy … Pending
  2025-523010-89-00 3
• Effect of vasopressin versus norepinephrine on post-operative mean pulmonary arterial pressure following pulmonary endarterectomy surgery, a … Pending
  2025-525153-39-00 5 "Chronic thromboembolic pulmonary hypertension"
• Phase 2 Study of REGN13335 in Adult Participants with Pulmonary Arterial Hypertension (PAH) Recruiting
  2024-514754-79-00 4 2026-05-06 "Pulmonary Arterial Hypertension (PAH)"
• RECOMPENSE: Right vEntricular COMPENsation with SotatercEpt. A prospective single arm open label phase IV study to evaluate the effects of s … Recruiting
  2024-512543-23-00 6 2025-05-14
• OLE study in participants with pulmonary arterial hypertension Recruiting
  2023-505539-11-00 10 2023-04-06 "Pulmonary Arterial Hypertension"
• A Long-term Follow-up Study of Sotatercept for PAH Treatment Recruiting
  2023-509138-21-00 5 2021-08-26 "Pulmonary Arterial Hypertension (PAH)"
• COMMODITIES : Comparison of initial dual oral COMbination therapy to MOnotherapy in pulmonary arterial hypertension with cardiovascular como … Recruiting
  2023-509891-40-00 5 2026-04-28
• An Open-Label Extension Study for Participants with PAH Who Have Previously Participated in a Clinical Trial with PF-07868489 Recruiting
  2025-521155-23-00 4 2025-12-19 "Pulmonary Arterial Hypertension"
• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) Recruiting
  2024-513613-12-00 9 2025-09-18 "Part A: Healthy volunteers (Part A is not applicable to the "
• Open-label, single-arm, non-controlled trial to evaluate the safety and tolerability of treprostinil sodium in children below the age of 18 … Recruiting
  2023-505082-91-00 5 2024-05-29 "Pulmonary Arterial Hypertension (PAH)"
• Randomized trial comparing efficacy and safety of initial triple therapy including parenteral treprostinil to initial double oral therapy in … Recruiting
  2023-504351-26-01 11 2023-12-06 "Pulmonary arterial hypertension (group I)"
• Sotatercept in Children with Pulmonary Artery Hypertension on Standard of Care Recruiting
  2023-504861-22-00 4 2023-05-05
• A clinical study of sotatercept in people with pulmonary arterial hypertension (MK-7962-038) Recruitment ended
  2025-521970-33-00 5 2025-12-19 "​​Pulmonary Arterial Hypertension (PAH)"
• A clinical study of sotatercept in people with pulmonary arterial hypertension Recruitment ended
  2024-518687-12-00 4 2025-06-19 "Pulmonary Arterial Hypertension (PAH)"
• A Study to Learn How the Study Medicine Called PF-07868489 is Tolerated and Acts in Healthy Adult People and People With Pulmonary Arterial … Recruitment ended
  2024-514064-17-00 3 2025-05-23 "Pulmonary Arterial Hypertension"
• An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arte … Recruitment ended
  2023-506334-75-00 5 2024-07-12 "Pulmonary Arterial Hypertension"
• A Phase 3 study to compare long-term efficacy and safety of macitentan 75 mg versus 10 mg in Pulmonary Arterial Hypertension. Recruitment ended
  2024-515669-32-00 5 2020-06-30
• A clinical study to confirm the doses of selexipag to be used in children with pulmonary arterial hypertension Recruitment ended
  2022-503042-42-00 4 2018-07-23 "Pulmonary Arterial Hypertension"
• Riociguat for treatment of PAH in children from 6 to less than 18 years old Recruitment ended
  2023-503536-40-00 5 2016-02-23 "Pulmonary arterial hypertension (PAH)"
• A Clinical Study to Compare the Impact of Multiple-dose Oral Administration of Macitentan, 10 mg versus 75 mg on Endothelin-1 Clearance, End … Ended
  2024-517652-35-00 2 2025-04-01 "Pulmonary Arterial Hypertension"
• An Early Phase Study to Investigate the Safety and Efficacy of HS135 in Adult Patients With Pulmonary Arterial Hypertension (PAH) Ended
  2023-510452-23-00 3 2024-10-29
• A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arteri … Ended
  2022-502378-17-00 4 2024-03-20 "Pulmonary Arterial Hypertension"
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the … Ended
  2023-503614-80-00 5 2023-12-14 "Pulmonary Arterial Hypertension"
• Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long Term Extension (IMPAHCT-FUL) Ended
  2023-508735-31-00 5 2023-05-05 "Pulmonary Arterial Hypertension (PAH)"

Showing 1–24 of 30 trials